Thyrocare Technologies Approves MOA Amendments at AGM

Thyrocare Technologies Limited announced that its members approved amendments to the Memorandum of Association (MOA) at its 26th Annual General Meeting (AGM) held on June 30, 2026. Key changes include substituting headings for main objects and ancillary matters, adding a new sub-clause for establishing and operating diagnostic facilities (including home collection, labs, radiology, pathology centers, etc.), and aligning references with the Companies Act, 2013. The amendments aim to broaden the company's scope in healthcare and diagnostic services, including digital platforms and manufacturing/distribution of medical equipment. The company also updated its website with this information.